Tambi Brian

Director at AKORN INC · on record since Aug 11, 2009
Director at AMEXDRUG CORP · on record since Sep 14, 2012
Director at Insys Therapeutics, Inc. · on record since May 16, 2013

Insider trading activity of Tambi Brian

Transactions on record: 55; since Aug 11, 2009

Open-market buys: 1; $27.6K

Open-market sells: 10; $3.7M

Companies traded: 3; last filing May 13, 2019

Figures computed from official regulatory filings — .

Companies where Tambi Brian has traded

AKORN INC27 tx · $2.6M · May 13, 2019
Insys Therapeutics, Inc.27 tx · $2M · May 14, 2018
AMEXDRUG CORP1 tx · Sep 14, 2012

Track record of Tambi Brian

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Tambi Brian

Co-insiders of Tambi Brian

KAPOOR JOHN NAKORN INC +1
MEYER STEVEN JAKORN INC +1
ABRAMOWITZ KENNETHAKORN INC
Akorn Holdings, L.P.AKORN INC
Alam Abu SAKORN INC
AMEXDRUG CORPAMEXDRUG CORP
AMIN JACKAMEXDRUG CORP
Babich Michael LInsys Therapeutics, Inc.
BAKER DARRYL SInsys Therapeutics, Inc.
BAYSTAR CAPITAL II LPAKORN INC
Baystar Capital Management, LLCAKORN INC
BOHLEN ELIZABETHInsys Therapeutics, Inc.
BONACCORSI JOSEPHAKORN INC
Boothe DouglasAKORN INC
BRENNAN DANIELInsys Therapeutics, Inc.
Del Fosse FrancInsys Therapeutics, Inc.
DERBY STEVENAKORN INC
Dick Timothy AAKORN INC
Dillaha LarryInsys Therapeutics, Inc.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
AKORN INCListing unverified	May 13, 2019	Award	30,760	0.00 USD	—	SEC
AKORN INCListing unverified	May 13, 2019	AwardD (derivative)	58,775	0.00 USD	—	SEC
Insys Therapeutics, Inc.Listing unverified	May 14, 2018	Exercise	60,000	3.63 USD	$217.8K	SEC
Insys Therapeutics, Inc.Listing unverified	May 14, 2018	Award	4,000	0.00 USD	—	SEC
Insys Therapeutics, Inc.Listing unverified	May 14, 2018	Sell	-166,504	6.41 USD	$1.1M	SEC
Insys Therapeutics, Inc.Listing unverified	May 14, 2018	Exercise	33,654	0.61 USD	$20.5K	SEC
Insys Therapeutics, Inc.Listing unverified	May 14, 2018	ExerciseD (derivative)	-33,654	0.00 USD	—	SEC
Insys Therapeutics, Inc.Listing unverified	May 14, 2018	Exercise	68,850	1.62 USD	$111.5K	SEC
Insys Therapeutics, Inc.Listing unverified	May 14, 2018	OtherD (derivative)	-4,000	0.00 USD	—	SEC
Insys Therapeutics, Inc.Listing unverified	May 14, 2018	ExerciseD (derivative)	-68,850	0.00 USD	—	SEC
Insys Therapeutics, Inc.Listing unverified	May 14, 2018	ExerciseD (derivative)	-60,000	0.00 USD	—	SEC
AKORN INCListing unverified	Apr 23, 2018	Award	14,189	0.00 USD	—	SEC
AKORN INCListing unverified	Nov 22, 2017	Sell	-15,100	33.35 USD	$503.6K	SEC
AKORN INCListing unverified	Aug 9, 2017	Sell	-5,165	33.37 USD	$172.4K	SEC
AKORN INCListing unverified	May 5, 2017	Award	8,088	0.00 USD	—	SEC
Insys Therapeutics, Inc.Listing unverified	Feb 23, 2017	AwardD (derivative)	16,000	0.00 USD	—	SEC
Insys Therapeutics, Inc.Listing unverified	Feb 23, 2017	AwardD (derivative)	4,000	0.00 USD	—	SEC
AKORN INCListing unverified	Jul 6, 2016	Award	4,661	0.00 USD	—	SEC
AKORN INCListing unverified	Jul 6, 2016	AwardD (derivative)	11,602	0.00 USD	—	SEC
AKORN INCListing unverified	Jun 6, 2016	Exercise	25,000	2.61 USD	$65.3K	SEC
AKORN INCListing unverified	Jun 6, 2016	ExerciseD (derivative)	-25,000	0.00 USD	—	SEC
AKORN INCListing unverified	Jun 6, 2016	Exercise	25,000	6.62 USD	$165.5K	SEC
AKORN INCListing unverified	Jun 6, 2016	Sell	-25,000	30.73 USD	$768.3K	SEC
AKORN INCListing unverified	Jun 6, 2016	ExerciseD (derivative)	-25,000	0.00 USD	—	SEC
Insys Therapeutics, Inc.Listing unverified	May 4, 2016	AwardD (derivative)	25,000	0.00 USD	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
AKORN INCListing unverified	May 13, 2019	Award	30,760	0.00 USD	—	SEC
AKORN INCListing unverified	May 13, 2019	AwardD (derivative)	58,775	0.00 USD	—	SEC
Insys Therapeutics, Inc.Listing unverified	May 14, 2018	Exercise	60,000	3.63 USD	$217.8K	SEC
Insys Therapeutics, Inc.Listing unverified	May 14, 2018	Award	4,000	0.00 USD	—	SEC
Insys Therapeutics, Inc.Listing unverified	May 14, 2018	Sell	-166,504	6.41 USD	$1.1M	SEC
Insys Therapeutics, Inc.Listing unverified	May 14, 2018	Exercise	33,654	0.61 USD	$20.5K	SEC
Insys Therapeutics, Inc.Listing unverified	May 14, 2018	ExerciseD (derivative)	-33,654	0.00 USD	—	SEC
Insys Therapeutics, Inc.Listing unverified	May 14, 2018	Exercise	68,850	1.62 USD	$111.5K	SEC
Insys Therapeutics, Inc.Listing unverified	May 14, 2018	OtherD (derivative)	-4,000	0.00 USD	—	SEC
Insys Therapeutics, Inc.Listing unverified	May 14, 2018	ExerciseD (derivative)	-68,850	0.00 USD	—	SEC
Insys Therapeutics, Inc.Listing unverified	May 14, 2018	ExerciseD (derivative)	-60,000	0.00 USD	—	SEC
AKORN INCListing unverified	Apr 23, 2018	Award	14,189	0.00 USD	—	SEC
AKORN INCListing unverified	Nov 22, 2017	Sell	-15,100	33.35 USD	$503.6K	SEC
AKORN INCListing unverified	Aug 9, 2017	Sell	-5,165	33.37 USD	$172.4K	SEC
AKORN INCListing unverified	May 5, 2017	Award	8,088	0.00 USD	—	SEC
Insys Therapeutics, Inc.Listing unverified	Feb 23, 2017	AwardD (derivative)	16,000	0.00 USD	—	SEC
Insys Therapeutics, Inc.Listing unverified	Feb 23, 2017	AwardD (derivative)	4,000	0.00 USD	—	SEC
AKORN INCListing unverified	Jul 6, 2016	Award	4,661	0.00 USD	—	SEC
AKORN INCListing unverified	Jul 6, 2016	AwardD (derivative)	11,602	0.00 USD	—	SEC
AKORN INCListing unverified	Jun 6, 2016	Exercise	25,000	2.61 USD	$65.3K	SEC
AKORN INCListing unverified	Jun 6, 2016	ExerciseD (derivative)	-25,000	0.00 USD	—	SEC
AKORN INCListing unverified	Jun 6, 2016	Exercise	25,000	6.62 USD	$165.5K	SEC
AKORN INCListing unverified	Jun 6, 2016	Sell	-25,000	30.73 USD	$768.3K	SEC
AKORN INCListing unverified	Jun 6, 2016	ExerciseD (derivative)	-25,000	0.00 USD	—	SEC
Insys Therapeutics, Inc.Listing unverified	May 4, 2016	AwardD (derivative)	25,000	0.00 USD	—	SEC